Gangagen Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 4.40 Cr
- Company Age 24 Year, 5 Months
- Last Filing with ROC 31 Dec 2023
About Gangagen Biotechnologies
Gangagen Biotechnologies Private Limited (GBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 September 2000 and has a history of 24 years and five months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 December 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Leow Jeffrey, Kumud Sampath, Jayasheela Manur, and Two other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U72100KA2000PTC027824
- Company No.
027824
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2000
- Date of AGM
27 Jun 2024
- Date of Balance Sheet
31 Dec 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Gangagen Biotechnologies?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Leow Jeffrey  | Director | 15-Dec-2020 | Current |
Kumud Sampath  | Director | 15-Dec-2020 | Current |
| Jayasheela Manur | Director | 17-Dec-2018 | Current |
| Tanjore Soundararajan | Director | 23-Apr-2015 | Current |
| Suchad Chiaranussati | Director | 15-Dec-2020 | Current |
Financial Performance of Gangagen Biotechnologies.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gangagen Biotechnologies?
Unlock access to Gangagen Biotechnologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pi Industries LimitedTanjore Soundararajan is a mutual person
Ikp Knowledge ParkTanjore Soundararajan is a mutual person
Ahammune Biosciences Private LimitedTanjore Soundararajan is a mutual person
Pi Health Sciences LimitedTanjore Soundararajan is a mutual person
- Open Source Pharma Foundation
Tanjore Soundararajan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gangagen Biotechnologies?
Unlock and access historical data on people associated with Gangagen Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gangagen Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gangagen Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
